These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7736924)

  • 1. Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.
    Laurenzana EM; Sorrels SL; Owens SM
    Drug Metab Dispos; 1995 Feb; 23(2):271-8. PubMed ID: 7736924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.
    Cribb A; Nuss C; Wang R
    Drug Metab Dispos; 1995 Jul; 23(7):671-5. PubMed ID: 7587952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of debrisoquin clearance in perfused rat livers and inhibition of dextromethorphan metabolism in human liver microsomes by 4-hydroxydebrisoquin or other metabolites of debrisoquin.
    Jaruratanasirikul S; Cooper AD; Blaschke TF
    Drug Metab Dispos; 1992; 20(3):379-82. PubMed ID: 1355711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
    Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
    Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens.
    Schulz-Utermoehl T; Edwards RJ; Boobis AR
    Drug Metab Dispos; 2000 May; 28(5):544-51. PubMed ID: 10772633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney.
    Okita JR; Johnson SB; Castle PJ; Dezellem SC; Okita RT
    Drug Metab Dispos; 1997 Aug; 25(8):1008-12. PubMed ID: 9280410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
    Leeder JS; Gaedigk A; Lu X; Cook VA
    Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
    Churchill PF; Churchill SA; Martin MV; Guengerich FP
    Mol Pharmacol; 1987 Feb; 31(2):152-8. PubMed ID: 3543648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
    Wrighton SA; Vandenbranden M; Becker GW; Black SD; Thomas PE
    Mol Pharmacol; 1992 Jan; 41(1):76-82. PubMed ID: 1370708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization.
    Sakamoto K; Kirita S; Baba T; Nakamura Y; Yamazoe Y; Kato R; Takanaka A; Matsubara T
    Arch Biochem Biophys; 1995 Jun; 319(2):372-82. PubMed ID: 7786018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a form-specific, inhibitory antibody against rat cytochrome P450 2B1 using a synthetic peptide antigen against a putative substrate binding site.
    Charnecki J; Putt D; Kim EY; Kim H
    Biochem Biophys Res Commun; 1995 Nov; 216(3):1024-33. PubMed ID: 7488175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats.
    Cooper KO; Reik LM; Jayyosi Z; Bandiera S; Kelley M; Ryan DE; Daniel R; McCluskey SA; Levin W; Thomas PE
    Arch Biochem Biophys; 1993 Mar; 301(2):345-54. PubMed ID: 7681660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
    Barham HM; Lennard MS; Tucker GT
    Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-peptide antibodies to the P4502D subfamily in rat, dog and man.
    Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
    Xenobiotica; 1995 Nov; 25(10):1103-9. PubMed ID: 8578766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
    Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T
    Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1).
    Yamamoto AM; Cresteil D; Boniface O; Clerc FF; Alvarez F
    Eur J Immunol; 1993 May; 23(5):1105-11. PubMed ID: 7682958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.